THE ROLE OF E-CADHERIN CELL ADHESION MOLECULE IN HUMAN ONTOGENESIS IN NORM AND PATHOLOGY

Abstract

E-cadherin is one of the most important cell adhesion molecules, which plays a key role in embryogenesis and adult tissues under normal conditions and during tumor development. Molecules of E-cadherin are located at the epitheliocyte surface and take part in the adhesion contacts formation which are a characteristic feature of epithelial tissues. The role of E-cadherin is not only in the maintenance of intercellular adhesion, but also in provision of cell proliferation and differentiation through participation in the realization of a number of signaling pathways, the main of which is the canonical Wnt signaling pathway. This review provides basic information regarding the role of E-cadherin in human ontogenesis in norm and pathology

Keywords

E-cadherin / cell adhesion

References

[1] Жункейра Л. К. и Карнейро Ж. Гистология: учебное пособие. Атлас. М., ГЭОТАР-медиа, 2009.

[2] Киясов А. П., Гумерова А. А. и Титова М. А. Мезенхимальноэпителиальная трансформация. Клеточные технологии в биологии и медицине, 2006, № 3, с. 150-154.

[3] Пак Д. Д., Франк Г. А. и Рябов И. И. Прогностическое значение некоторых клинико-морфологических факторов при инвазивном дольковом раке молочной железы. Рос. онкол. журн., 2006, № 1, с. 17-21.

[4] Репин В. С. и Сабурина И. Н. Обратимые эпителио-мезенхимальные трансформации клеток в эмбриогенезе и постнатальном обновлении тканей. Клеточная трансплантология и тканевая инженерия, 2007, т. 1, № 3, с. 64-72.

[5] Франк Г. А., Завалишина Л. Э. и Андреева Ю. Ю. Состояние внеклеточного матрикса и маркеры адгезии в уротелиальном раке мочевого пузыря. Арх. пат., 2005, т. 67, № 3, с. 11-14.

[6] Чипышева Т. А., Гельштейн В. И., Ермилова В. Д. и др. Экспрессия молекул межклеточной адгезии Е-кадхерина и В-катенина в инфильтративных карциномах молочной железы. Арх. пат., 2003, т. 65, № 3, с. 3-7.

[7] Чипышева Т. А., Ермилова В. Д., Вишневская Я. В. и др. Экспрессия Е-кадгерина как дифференциально-диагностический тест для дольковых инфильтративных раков молочной железы. Арх. пат., 2005, т. 67, № 6, с. 24-27.

[8] Andrews J. L., Kim A. C. and Hens J. R. The role and function of cadherins in the mammary gland. Breast Cancer Res., 2012, № 14, p. 203-212.

[9] Baranwal S. and Alahari S. K. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem. Biophys. Res. Commun., 2009, № 384, p. 6-11.

[10] Bellacosa A. and Larue L. PI3K/AKT Pathway and the Epithelial-Mesenchymal Transition. In: Cancer Genome and Tumor Microenvironment. N. Y., Springer, 2010, p. 11-33.

[11] Brett A., Pandey S. and Fraizer G. The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells. Mol. Cancer, 2013, v. 12, № 3, p. 1476-1488.

[12] Brzozowska A., Sodolski T. and Duma D. Evaluation of prognostic parameters of E-cadherin status in breast cancer treatment. Ann. Agricul. Environ. Med., 2012, v. 19, № 3, p. 541-546.

[13] Chaffer C. L., Thompson E. W. and Williams E. D. Mesenchymal to epithelial transition in development and disease. Cells, Tissues, Organs, 2007, v. 185, p. 7-19.

[14] Chan A. O. E-cadherin in gastric cancer. World J. Gastroenterol., 2006, v. 12, № 2, p. 199-203.

[15] Clevers H. Wnt/β-catenin signaling in development and disease. Cell, 2006, v. 127, p. 469-480.

[16] De Vries W. N., Evsikov A. V., Haac B. E. et al. Maternal β-catenin and E-cadherin in mouse development. Development, 2004, v. 131, p. 4435-4445.

[17] Faria G., Cardoso M. J., Martins D. et al. P-cadherin as prognostic factor for loco-regional relapse in breast cancer. Acta Med. Port., 2012, 25, № 2, p. 97-105.

[18] Gruver A. M., Portier B. P. and Tubbs R. R. Molecular pathology of breast cancer. Arch. Pathol. Lab. Med., 2011, v. 135, p. 544-557.

[19] Halbleib J. M. and Nelson W. J. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev., 2006, v. 20, № 23, p. 3199-3214.

[20] Hay E. D. Development of the vertebrate cornea. Inf. Rev. Cytol., 1980, v. 63, p. 263-312.

[21] Kotb A. M., Hierholzer A. and Kemler R. Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation. Breast Cancer Res., 2011, v. 13, № 5, p. R104.

[22] Kowalski P.J., Rubin M. A. and Kleer C. G. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res., 2003, v. 5, № 6, p. R217-R222.

[23] Li D.-M. and Feng Y-M. Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets. Breast Cancer Res. Treat., 2011, v. 128, № 1, p. 7-21.

[24] Liu T., Zhang X., Shang M. et al. Dysregulated expression of Slug, Vimentin and E-cadherin correlates with poor clinical outcome in patients with Basal-like Breast Cancer. J. Surg. Oncol., 2012, v 107, № 2, p. 188-194.

[25] Makrilla N., Kollias A., Manolopoulos L. et al. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest., 2009, № 27, p. 1023-1037.

[26] Niessen C. M. and Gottardi C. J. Molecular components of the adherens junction. Biochim. Biophys. Acta, 2008, v. 1778, № 3, p. 562-571.

[27] Oas R. G., Nanes B. A., Esimai C. C. et al. p120-catenin and β-catenin differentially regulate cadherin adhesive function. Mol. Biol. Cell., 2013, v. 24, № 6, p. 704-714.

[28] Oesterreich S., Deng W., Jiang S. et al. Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. Cancer Res., 2003, v. 63, p. 5203-5208.

[29] Paredes J., Figueiredo J., Albergaria A. et al. Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim. Biophys. Acta, 2012, v. 1826, p. 297-311.

[30] Pecina-Slaus N. Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int., 2003, v 317, № 2, p. 1475-2867.

[31] Priya R., Yap A. S. and Gomez G. A. E-cadherin supports steady-state Rho signaling at the epithelial zonula adherens. Differentiation, 2013, v. 86, № 3, p. 133-140.

[32] Quang B. T., Mani M., Markova O. et al. Principles of E-cadherin supramolecular organization in vivo. Curr. Biol., 2013, № 23, p. 2197-2207.

[33] Reuter C. W., Morgan M. A. and Bergmann L. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? Blood, 2000, v. 96, № 5, p. 1655-1669.

[34] Reynolds A. B. and Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene, 2004, № 23, p. 7947-7956.

[35] Rezaei M., Friedrich K., Wielockx B. et al. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression. Breast Cancer Res., 2012, v. 14, № 6, p. R154-R168.

[36] Rijsewijk F., Schuermann M., Wagenaar E. et al. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell, 1987, v. 50, № 4, p. 649-657.

[37] Roy F. and Berx G. The cell-cell adhesion molecule E-cadherin. Cell. Mol. Life Sci., 2008, v. 65, № 23, p. 3756-3788.

[38] Saadatmand E. M., Kruijf E. M., Sajet A. et al. Expression of cell adhesion molecules and prognosis in breast cancer. British J. Surg., 2013, v. 100, № 2, p. 252-260.

[39] Schmidmaier R. and Baumann P. Anti-adhesion evolves to a promising therapeutic concept in oncology. Curr. Med. Chem., 2008, № 15, p. 978-990.

[40] Sethi S., Sarkar F. H., Ahmed Q. et al. Molecular markers of epithelial-to-mesenchymal transition are assotiated with tumor aggressiveness in breast carcinoma. Translat. Oncol., 2011, № 4, p. 212-216.

[41] Shimamura K., Hirano S., McMahon A. P. et al. Wnt-1-dependent regulation of local E-cadherin and αN-cadherin expression in the embryonic mouse brain. Development, 1994, v. 120, № 5, p. 2225-2234.

[42] Singhai R., Patil V. W., Jaiswal S. R. et al. E-cadherin as a diagnostic biomarker in breast cancer. N. Am. J. Med. Sci., 2011, v. 3, № 5, p. 227-233.

[43] Stepniak E., Radice G. L. and Vasioukhin V. Adhesive and signaling functions of cadherins and catenins in vertebrate development. Cold Harb. Perspect. Biol., 2009, v. 1, № 5, p. 2949-2972.

[44] Suriano G., Mulholland D., de Wever O. et al. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene, 2003, № 22, p. 5716-5719.

[45] Tian X., Liu Z., Zhang J. et al. E-cadherin/β-catenin complex and the epithelial barrier. J. Biomed. Biotechnol., 2011, v. 104, № 4, p. 605-617.

[46] Vasioukhin V., Bauer C., Degenstein L. et al. Hyperproliferation and defects in epithelial polarity upon conditional ablation of α-catenin in skin. Cell, 2001, v. 104, № 4, p. 605-617.

[47] Weigelt B., Peterse J. L. and van’t Veer L. J. Breast cancer metastasis: markers and models. Nature Rev. Cancer, 2005, v. 5, № 8, p. 591-602.

[48] Wells A., Chao Y. L., Grahovac J. et al. Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front. Biosci., 2011, № 16, p. 815-837.

[49] Wheelock M. J. and Johnson K. R. Cadherin-mediated cellular signaling. Curr. Opin. Cell Biol., 2003, № 15, p. 509-514.

[50] Yang J. and Weinberg R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 2008, № 14, p. 818-829.

[51] Zasadkevich Y.M., Brilliant A. A. and Sazonov S. V. Characteristics of the relation between epithelial-mesenchymal transition and proliferative activity in breast carcinomas. Eur. J. Cancer, 2013, v. 49, № 2, p. S216.

[52] Zeisberg M. and Neilson E. G. Biomarkers of epithelial-mesenchymal transitions. J. Clin. Invest., 2009, v. 119, № 6, p. 1429- 1437.

RIGHTS & PERMISSIONS

Eco-Vector